ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Study Examines Lung Cancer Among Lifelong Nonsmokers

October 31, 2008

Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial

October 28, 2005

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Women’s Health: Treatment to Move Toward Pre-Cancer, Klausner Says

December 5, 1997

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

Upton Promises “Minimal Disruption” As Result of Changes; Centers Program Probably To Move

January 20, 1978